Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
July 27, 2026
Sidelining cancer treatment’s side effects through exercise, nutrition, prehab and rehab
In this episode of Bench to Bedside and Beyond, we talk to a prostate cancer survivor and the medical director of Fred Hutch’s cancer rehab about treatment’s aftermath
FDA approves new breast cancer drug based on VIKTORIA-1 study results
New targeted drug brings ‘big change, big benefit,’ per Fred Hutch’s Dr. Sara Hurvitz, who led the study
Red meat in moderation: better for you, better for the environment
Don’t forget to add some green veggies to those red-white-and-blue barbecues!
Here comes the sun! What’s your skin strategy?
Avoiding sunburn is the first step in preventing deadly skin cancer melanoma
Beyond the 5-year myth: How survivorship care helps cancer patients live well
In this episode of From Bench to Bedside and Beyond, we discuss why Survivorship programs exist and how Fred Hutch’s program is changing to better serve patients
Lung cancer researchers, advocates gather in Seattle
SPORE scientists talk T cells, new targeted therapies, the tumor microenvironment and more at annual meeting
Pancreatic cancer experts, patients applaud new KRAS inhibitor therapy
Hope for patients and oncologists: ‘We’re at the beginning of a paradigm shift’
From treatment to thriving: Redefining cancer survivorship
In this episode of From Bench to Bedside and Beyond, we discuss how the growing field of survivorship supports patients as they navigate what's next
What cancer researchers, clinicians and patients say about ‘game-changing’ GLP-1s
Yes, you lose weight, but there are definitely trade-offs; cancer prevention role of new weight loss drugs still being studied
Is there a way to boost immunotherapy response?
American Cancer Society grant will fund new analysis of how advanced melanoma evades the immune system
New grant funds research on circadian disruption and its potential link to liver cancer
In this episode of From Bench to Bedside and Beyond, Dr. Trang VoPham talks about her research into solar jet lag, including how it can impact your health
Does solar jet lag contribute to liver cancer?
Fred Hutch researcher will use American Cancer Society grant to determine if circadian disruption increases risk for hepatocellular carcinoma
Fred Hutch brings together rare cancer community
Patients and caregivers share frustrations, practical realities of rare cancer life at TRACER program’s first education symposium
Can you get a cancer screening without insurance?
Uninsured? Underinsured? Mammograms and other preventive cancer screenings are still available
What’s the psychology behind using dietary supplements?
In this episode of From Bench to Bedside and Beyond, Dr. Jonathan Bricker explains why we choose the ‘quick fix’ over tried-and-true cancer prevention methods
Supplements don’t prevent cancer, studies show
Fred Hutch research finds some supplements offer little benefit, some may increase cancer risk and some can interfere with treatment
Cancer Action Plan of Washington (CAPOW) packs a punch
New 5-year plan maps out key strategies to reduce cancer rates, deaths by boosting health literacy, screening, prevention and equity efforts
Getting the best bang for your cancer prevention buck
Fred Hutch experts weigh in on budget-friendly ways to cut disease risk and stay healthy in the new year
SABCS25: What’s new in breast cancer research?
Advances include a new endocrine therapy, the use of ctDNA to predict response and modifying PET/CTs to better track bone metastases
Breast Cancer Research Foundation to fund seven Cancer Consortium researchers
BCRF awards $2.6M in grants to Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium researchers